Aoxing Pharmaceutical Company Inc (AOXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,804 | -6,020 | -3,424 | -449 | -15,820 |
| Depreciation Amortization | 1,731 | 842 | 568 | 275 | 1,080 |
| Accounts receivable | -55 | 80 | 10 | 8 | -764 |
| Accounts payable and accrued liabilities | 585 | -340 | 25 | -67 | 40 |
| Other Working Capital | -302 | -2,094 | -1,447 | -558 | -680 |
| Other Operating Activity | 6,528 | 982 | 786 | 232 | 14,819 |
| Operating Cash Flow | $-8,317 | $-6,549 | $-3,481 | $-559 | $-1,326 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -439 | -388 | -291 | -69 | -752 |
| Investing Cash Flow | $-439 | $-388 | $-291 | $-69 | $-752 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -433 | -189 | -3,385 | N/A | 2,894 |
| Debt Issued | 10,221 | 10,309 | 10,294 | 7,108 | -72 |
| Debt Repayment | -796 | -4,092 | -4,086 | -3,949 | N/A |
| Financing Cash Flow | $8,992 | $6,028 | $2,824 | $3,159 | $2,821 |
| Exchange Rate Effect | 90 | 20 | 3 | -10 | 169 |
| Beginning Cash Position | 3,683 | 3,683 | 3,683 | 3,683 | 2,771 |
| End Cash Position | 4,008 | 2,794 | 2,737 | 6,204 | 3,683 |
| Net Cash Flow | $325 | $-889 | $-946 | $2,522 | $912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,317 | -6,549 | -3,481 | -559 | -1,326 |
| Capital Expenditure | -439 | -388 | -291 | -69 | -752 |
| Free Cash Flow | -8,757 | -6,937 | -3,772 | -628 | -2,079 |